Nicole Wares
Acute Care · Belleville, NJNPI 1588131551
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Boehringer Ingelheim at 26.2% of the total. Among acute care clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$707
- Merck$439
- Amgen$322
- Cvrx, Inc.$223
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$111
- Bayer$105
- plus $792 from 19 others
What the payments were for
- Food & beverage$2,700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 32 | $707 |
| Merck | 28 | $439 |
| Amgen | 24 | $322 |
| Cvrx, Inc. | 11 | $223 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $111 |
| Bayer | 5 | $105 |
| Novo Nordisk | 5 | $92 |
| Pfizer | 5 | $80 |
| Johnson & Johnson | 5 | $75 |
| Amarin Pharma, Inc. | 5 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $58 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $58 |
| Atricure, Inc. | 2 | $55 |
| Irhythm Technologies, Inc. | 3 | $53 |
| Kestra Medical Technology Services, Inc. | 2 | $47 |
| AstraZeneca | 3 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Edwards Lifesciences | 1 | $20 |
| Altathera Pharmaceuticals LLC | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Althera Pharmaceuticals LLC | 1 | $15 |
| Baxter Healthcare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$238
How this compares
$2,700 in reported general payments places this provider in the 90th percentile of 656 acute care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 13 | $9,080 |
| Ezetimibe | 14 | $595 |
| Atorvastatin Calcium | 32 | $428 |
| Metoprolol Succinate | 38 | $345 |
| Amlodipine Besylate | 25 | $191 |
| Rosuvastatin Calcium | 12 | $130 |
| Carvedilol | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other acute care in Belleville
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
- Hanane ChaibainouWestampton$16K
- Jennifer McCarthyNewark$16K
- Jennifer HarrarCamden$16K
- Vincent FroncekFlemington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.